Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 16, Issue 5, 1998, Pages 569-572

  Al Awadhi, A M ^a   Olusi, S O ^a   Al Zaid, N S ^a   Prabha, K ^a   Al Jarallah, K H ^a   Ahmed, A H ^b   Al Salem, I ^b   Sedeqi, H ^b   Atteyah, Y ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

Author keywords

Deoxypyridinoline; Disease activity; Rheumatoid arthritis; Spot urine concentrations; Type 1 collagen cross linked N telopeptides

Indexed keywords

COLLAGEN TYPE 1; DEOXYPYRIDINOLINE;

ADULT; ARTICLE; BONE MATRIX; BONE METABOLISM; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CROSS LINKING; DISEASE ACTIVITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URINARY EXCRETION; URINE LEVEL;

ADULT; AMINO ACIDS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; COLLAGEN; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES; SEVERITY OF ILLNESS INDEX;

EID: 0031659972     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. GABRIEL SE, LUTHRA HS: Rheumatoid arthritis: Can the long term outcome be altered? Mayo Clin Proc 1988; 63: 58-68.
2. KUSHNER I: C-reactive protein in rheumatology. Arthritis Rheum 1991; 34: 1065-8.
3. SHARP JT: Radiological assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 1989; 32: 221-9.
4. SCOTT DL, HOUSSIEN DA: Clinical and laboratory assessment in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1996; 35: 6-9.
5. BOERS M, VAN RIEL PL, FELSON DT, TUGWELL P: Assessing the activity of rheumatoid arthritis. Baillières Clin Rheumatol 1995; 9: 305-17.
6. FELSON DT, ANDERSON JJ, BOERS M et al.: American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
7. BERMAN P, MANICOURT D, MARTIN P, ORLOFFS S: Regional bone calcium turnover rate in rheumatoid arthritis. Comparison with the disease activity. In GORINI S et al. (Eds.): Advances in Inflammation Research. Rheumatoid Arthritis. Vol. 3, New York, Raven Press 1982; 302-12.
8. MABUYI JM, DEQUEKER J, TEBLICK M, MERLEVEDE M: Relevance of urinary excretion of alcian blue-glycosaminoglycan complexes and hydroxyproline to disease activity in rheumatoid arthritis. J Rheumatol 1982; 9: 579-83.
9. SAMBROOK PN, ANSELL BM, FOSTER S: Bone turnover in early rheumatoid arthritis. Biochemical and kinetic indexes. Ann Rheum Dis 1985; 44: 575-79.
10. HAKALA M, RISTELI L, MANELIUS J et al.: Increased type 1 collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis 1993; 52: 866-9.
11. RISTELI J, ELOMAA I, NIEMI S et al.: Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type 1collagen: A new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635-40.
12. HAKALA M, AMAN S, LUUKKAINEN R, RISTELI L et al.: Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 889-90.
13. KOLLERUP G, HANSEN M, HORSLEV-PETERSEN K: Urinary hydroxypyridimium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effect of methylprenisolone. Br J Rheumatol 1994; 33: 816-20.
14. HELLIO LE GRAVERAND MP, TRON AM, ICHOU M et al.: Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis. Br J Rheumatol 1996; 35: 1091-5.
15. ARNETT PC, EDWORTHY SM, BLOCK DA et al.: The American Rheumatism Association, 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
16. HANSON DA, WEIS MA, BOLLEN AM et al.: A specific immunoassay for monitoring human bone resorption. Quantitation of type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992; 7: 1257-8.
17. SONE T, MIYAKE M, TAKEDA N, FUKUNAGA M: Urinary excretion of type 1 collagen cross-linked N-telopeptides in healthy Japanese adults. Age-and sex-related changes and reference limits. Bone 1995; 17: 335-9.
18. EASTELL R, HAMPTON L, COLWELL A et al.: Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In CRISTIANSEN C and OVERGAARD K (Eds.): Osteoporosis, Copenhagen, Osteopress, pp 469-70.
19. DELMAS DD, SCHLEMMER A, GINEYTES E et al.: Urinary excretion of pyridinoline cross-links correlated with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991; 6: 639-44.